DZ1550A1 - Vaccin depourvu de cellules contre le virus de la maladie marek. - Google Patents

Vaccin depourvu de cellules contre le virus de la maladie marek.

Info

Publication number
DZ1550A1
DZ1550A1 DZ910174A DZ910174A DZ1550A1 DZ 1550 A1 DZ1550 A1 DZ 1550A1 DZ 910174 A DZ910174 A DZ 910174A DZ 910174 A DZ910174 A DZ 910174A DZ 1550 A1 DZ1550 A1 DZ 1550A1
Authority
DZ
Algeria
Prior art keywords
disease virus
cell
vaccine against
marek
free vaccine
Prior art date
Application number
DZ910174A
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ1550(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of DZ1550A1 publication Critical patent/DZ1550A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361—Methods of inactivation or attenuation
    • C12N2710/16364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DZ910174A 1990-12-24 1991-12-23 Vaccin depourvu de cellules contre le virus de la maladie marek. DZ1550A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (1)

Publication Number Publication Date
DZ1550A1 true DZ1550A1 (fr) 2002-02-17

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ910174A DZ1550A1 (fr) 1990-12-24 1991-12-23 Vaccin depourvu de cellules contre le virus de la maladie marek.

Country Status (17)

Country Link
US (1) US5378467A (fr)
EP (1) EP0496135B1 (fr)
JP (1) JP3410744B2 (fr)
KR (1) KR100187317B1 (fr)
CN (1) CN1034554C (fr)
AT (1) ATE109007T1 (fr)
CA (1) CA2058386C (fr)
DE (1) DE69103130T2 (fr)
DK (1) DK0496135T3 (fr)
DZ (1) DZ1550A1 (fr)
ES (1) ES2061165T3 (fr)
HU (2) HUT62200A (fr)
IL (1) IL100386A (fr)
MX (1) MX9102757A (fr)
NZ (1) NZ241122A (fr)
SA (1) SA92120430B1 (fr)
ZA (1) ZA9110022B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (fr) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccin prophylactique contre la maladie de marek chez les oiseaux et son procede de preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
EP0703294A1 (fr) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Vaccin viral contre la maladie de Marek
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
EP2384761B1 (fr) 2010-05-07 2013-09-04 Deutsches Krebsforschungszentrum Parvovirus de rongeurs modifié capable de se propager et se répandre par des gliomes humains
MX2020006343A (es) 2017-12-20 2020-09-03 Intervet Int Bv Diluyente mejorado para vacuna de herpesvirus alfa asociado con celulas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
HU914111D0 (en) 1992-03-30
DK0496135T3 (da) 1994-11-28
ZA9110022B (en) 1992-10-28
JPH04295433A (ja) 1992-10-20
HU210344A9 (en) 1995-04-28
US5378467A (en) 1995-01-03
EP0496135A2 (fr) 1992-07-29
CA2058386A1 (fr) 1992-06-25
HUT62200A (en) 1993-04-28
SA92120430B1 (ar) 2004-05-31
DE69103130T2 (de) 1994-12-01
ATE109007T1 (de) 1994-08-15
IL100386A0 (en) 1992-09-06
NZ241122A (en) 1992-10-28
CN1034554C (zh) 1997-04-16
CA2058386C (fr) 2003-02-11
KR100187317B1 (ko) 1999-05-01
ES2061165T3 (es) 1994-12-01
CN1064409A (zh) 1992-09-16
KR920011520A (ko) 1992-07-24
MX9102757A (es) 1992-07-01
JP3410744B2 (ja) 2003-05-26
EP0496135A3 (fr) 1992-08-05
DE69103130D1 (de) 1994-09-01
IL100386A (en) 1995-07-31
EP0496135B1 (fr) 1994-07-27

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
KR890000105A (ko) 개의 관상 비루스 왁진
DZ1550A1 (fr) Vaccin depourvu de cellules contre le virus de la maladie marek.
DE3071594D1 (en) Feline infectious peritonitis virus, its preparation and vaccines containing it
IE780360L (en) Vaccine against "egg drop disease".
CA2116355A1 (fr) Mutants infectieux du virus de la rhinotracheite bovine et vaccins
GR3007856T3 (fr)
MX9602256A (es) Vacuna contra la enfermedad de marek.
IL86397A (en) Attenuated virus and vaccine therefrom for use against infections in fowls caused by turkey rhinotracheitis virus
ATE18007T1 (de) Hepatitisimpfstoff.
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
Paprocka Assessment of FMD virus propagation in cell culture system and inactivating preparations in order to obtain an effective vaccine.
TH12563EX (th) วีคซีนป้องกันไวรัสโรคมาเร็คชนิดปราศจากเซลล์
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
Von Ohlinger et al. Boar vaccination against Aujeszky's disease. 2. Communication: Virus excretion in nasal secretions and semen.
Joklik Antigenic relationships between the proteins of the three serotypes of reovirus.
RU94031386A (ru) Вакцина сухая культуральная против вирусного энтерита гусей и способ профилактики и лечения вирусного энтерита гусей
Lin et al. Protectivity of the Bivalent Marek's Disease Vaccines in Taiwan Local Chickens
Bexendale Cell-free Marek's Disease virus vaccine
FI893346A (fi) Icke-reverterande rna-virus.
TH14824B (th) วัคซีนสำหรับสัตว์ปีก
RO101948B1 (en) Bivalent inactivated vaccine against paramixo-virosis and newcastle disease at pigeons